Adenine Nucleotide Analogues Locked in a Northern Methanocarba Conformation: Enhanced Stability and Potency as P2Y1 Receptor Agonists-Reference-Cited by-同舟云学术

Adenine Nucleotide Analogues Locked in a Northern Methanocarba Conformation: Enhanced Stability and Potency as P2Y1 Receptor Agonists

Published:2002-04-12 Issue:10 Volume:45 Page:2090-2100
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Ravi R. Gnana¹,Kim Hak Sung¹,Servos Jörg¹,Zimmermann Herbert¹,Lee Kyeong¹,Maddileti Savitri¹,Boyer José L.¹,Harden T. Kendall¹,Jacobson Kenneth A.¹

Affiliation:

1. Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Building 8A, Room B1A-17, Bethesda, Maryland 20892-0810, Department of Pharmacology, University of North Carolina, School of Medicine, Chapel Hill, North Carolina 27599-7365, and AK Neurochemie, Biozentrum der J. W. Goethe-Universität, Marie-Curie-Strasse 9, D- 60439 Frankfurt am Main, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm010538v

Reference53 articles.

1. Towards a revised nomenclature for P1 and P2 receptors

2. Identification of the platelet ADP receptor targeted by antithrombotic drugs

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenosine A1R/A3R agonist AST-004 reduces brain infarction in mouse and rat models of acute ischemic stroke;Frontiers in Stroke;2022-11-22

2. Synthesis and Effect of Conformationally Locked Carbocyclic Guanine Nucleotides on Dynamin;Biomolecules;2022-04-16

3. Adenosine A1R/A3R Agonist AST-004 Reduces Brain Infarction in Mouse and Rat Models of Acute Ischemic Stroke;2022-03-17

4. Neuroprotective Roles of the Adenosine A3 Receptor Agonist AST-004 in Mouse Model of Traumatic Brain Injury;Neurotherapeutics;2021-10

5. The Therapeutic Potential of Purinergic Receptors in Alzheimer’s Disease and Promising Therapeutic Modulators;Mini-Reviews in Medicinal Chemistry;2021-06-30